Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/130971
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic |
Author: | O’Shea, C.J. Thomas, G. Middeldorp, M.E. Harper, C. Elliott, A.D. Ray, N. Lau, D.H. Campbell, K. Sanders, P. |
Citation: | European Heart Journal, 2021; 42(5):520-528 |
Publisher: | Oxford University Press |
Issue Date: | 2021 |
ISSN: | 0195-668X 1522-9645 |
Statement of Responsibility: | Catherine J O’Shea, Gijo Thomas, Melissa E Middeldorp, Curtis Harper, Adrian D Elliott, Noemi Ray ... et al. |
Abstract: | Aims: Our objective was to determine the ventricular arrhythmia burden in implantable cardioverter-defibrillator (ICD) patients during COVID-19. Methods and results: In this multicentre, observational, cohort study over a 100-day period during the COVID-19 pandemic in the USA, we assessed ventricular arrhythmias in ICD patients from 20 centres in 13 states, via remote monitoring. Comparison was via a 100-day control period (late 2019) and seasonal control period (early 2019). The primary outcome was the impact of COVID-19 on ventricular arrhythmia burden. The secondary outcome was correlation with COVID-19 incidence. During the COVID-19 period, 5963 ICD patients underwent remote monitoring, with 16 942 episodes of treated ventricular arrhythmias (2.8 events per 100 patient-days). Ventricular arrhythmia burden progressively declined during COVID-19 (P < 0.001). The proportion of patients with ventricular arrhythmias amongst the high COVID-19 incidence states was significantly reduced compared with those in low incidence states [odds ratio 0.61, 95% confidence interval (CI) 0.54–0.69, P < 0.001]. Comparing patients remotely monitored during both COVID-19 and control periods (n = 2458), significantly fewer ventricular arrhythmias occurred during COVID-19 [incident rate ratio (IRR) 0.68, 95% CI 0.58–0.79, P < 0.001]. This difference persisted when comparing the 1719 patients monitored during both the COVID-19 and seasonal control periods (IRR 0.69, 95% CI 0.56–0.85, P < 0.001). Conclusions: During COVID-19, there was a 32% reduction in ventricular arrhythmias needing device therapies, coinciding with measures of social isolation. There was a 39% reduction in the proportion of patients with ventricular arrhythmias in states with higher COVID-19 incidence. These findings highlight the potential role of real-life stressors in ventricular arrhythmia burden in individuals with ICDs. |
Keywords: | COVID-19; implantable cardioverter-defibrillator; ventricular arrhythmia; ventricular tachycardia, Ventricular fibrillation; remote monitoring |
Rights: | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. |
DOI: | 10.1093/eurheartj/ehaa893 |
Published version: | http://dx.doi.org/10.1093/eurheartj/ehaa893 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.